Curis (CRIS) Depreciation & Amortization (CF) (2010 - 2026)
Curis (CRIS) reported Depreciation & Amortization (CF) of $8000.0 for Q1 2026, down 86.44% on a YoY basis from $59000.0 in Q1 2025, and down 77.78% quarter-over-quarter from $36000.0 in Q4 2025.
Curis (CRIS) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Curis has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $8000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 86.44% year-over-year to $8000.0; the trailing twelve-month figure through Mar 2026 stood at $118000.0 (down 40.4% YoY), and the FY2025 full-year result was $169000.0, down 16.75% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $8000.0, down from $36000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $64000.0 in Q1 2023, with the low at $8000.0 in Q1 2026.
- Historically, Depreciation & Amortization (CF) has averaged $49117.6 across 5 years, with a median of $59000.0 in 2022.
- Annual changes were most pronounced in 2025 — Depreciation & Amortization (CF) soared 125.0% — and 2026, when it sank 86.44%.
- Curis' Depreciation & Amortization (CF) stood at $59000.0 in 2022, then increased by 8.47% to $64000.0 in 2023, then slumped by 75.0% to $16000.0 in 2024, then soared by 125.0% to $36000.0 in 2025, then tumbled by 77.78% to $8000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $8000.0 (Q1 2026), $36000.0 (Q4 2025), and $32000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 1,395.22 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 429,663.65 |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | 8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 36,000.00 |
| Dec 31, 2025 | 36,000.00 |
| Sep 30, 2025 | 32,000.00 |
| Sep 30, 2025 | 32,000.00 |
| Jun 30, 2025 | 42,000.00 |
| Jun 30, 2025 | 42,000.00 |
| Mar 31, 2025 | 59,000.00 |
| Mar 31, 2025 | 59,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Sep 30, 2024 | 61,000.00 |
| Sep 30, 2024 | 61,000.00 |
| Jun 30, 2024 | 62,000.00 |
| Jun 30, 2024 | 62,000.00 |
| Mar 31, 2024 | 64,000.00 |
| Mar 31, 2024 | 64,000.00 |
| Dec 31, 2023 | 64,000.00 |
| Dec 31, 2023 | 64,000.00 |